£55m large-scale GMP manufacturing centre in Stevenage receives planning permission

Published: 25-Aug-2015
Design & Build Research & Development

Expected to open in 2015 and create 150 jobs


Stevenage Borough Council in Hertfordshire, UK, has granted planning permission for the construction of a £55m large-scale GMP manufacturing centre in the town, which will be managed by the Cell Therapy Catapult.

First announced last December, the 7,200m2 manufacturing centre is expected to open in 2017 and create up to 150 jobs. It will be used for manufacturing products for late-phase clinical trials and commercial supply of advanced therapeutic medicinal products including cell and gene therapies.

Keith Thompson, CEO of the Cell Therapy Catapult, said: 'I am delighted that Stevenage Borough Council has granted permission to create a centre that will advance the industry into becoming a world leader in advanced therapy development and commercialisation.

'The large-scale GMP manufacturing centre will provide global scientific and medical communities with the assistance they need to turn research into products that have the potential to address many unmet medical needs.'

  • Companies:
  • Cell and Gene Therapy Catapult
See more

You may also like

Media

British cell and gene therapy accelerator releases annual report

Read more
The CGT Catapult has worked on more than 110 projects addressing industry challenges

Trending Articles

  1. What is ISO 8 cleanroom classification? Each cleanroom class is denoted by a maximum concentration of particles per cubic meter or cubic foot of air. ISO 8 is the second lowest cleanroom classification
  2. CleanLock Module: AES Clean Technology launches new cleanroom airlock The cleanroom provider has launched its new airlock, which offers a secure transition for people and materials entering and exiting cleanroom environments
  3. A guide to getting your first cleanroom quote The dynamic nature of facility requirements can cause challenges getting all the technical information together for an initial cleanroom build quotation. So what do you actually need for this stage? MRC System's Sam Hussein discusses
  4. Cleanroom tightness and room pressurisation: Discrepancy? A cascaded room-pressure regime has been considered for decades to prevent cross-contamination of different processes. But Harald Flechl from ISPE says today's tight cleanrooms must have leaks to ensure a room-pressure regulation - so why should we build tight cleanrooms?
  5. White Raven chooses CoCEPTIO, Jansen Group, and Close for new pharmaceutical cleanroom CoCEPTIO, Jansen Group, and Close have been making progress on the pharmaceutical contract manufacturer's new cleanroom in Belgium

Upcoming event

Lounges

23-25 April 2024 | Conference | Messe Karlsruhe, Germany See all

You may also like

Media

British cell and gene therapy accelerator releases annual report

The CGT Catapult has worked on more than 110 projects addressing industry challenges
Manufacturing

CGT Catapult collaborates with Freeline Therapeutics

Cell and Gene Therapy Catapult (CGT Catapult) has teamed up with Freeline Therapeutics to further develop its proprietary manufacturing platform at CGT Catapult’s large scale GMP manufacturing centre in Stevenage, UK
Design & Build

New funds for UK Cell & Gene Therapy Catapult manufacturing centre

An extra £12m funding will double the current capacity of the Cell and Gene Therapy Catapult manufacturing centre in Stevenage
Design & Build

Facilitating a revolution in medicine

The first-of-its-kind production facility for cell and gene therapy companies is being built in Stevenage, UK. Susan Birks spoke to CEO of The Cell and Gene Therapy Catapult, Keith Thompson, about the design of this groundbreaking facility
Design & Build

Construction starts at Cell Therapy Catapult’s £55m cell and gene therapy manufacturing centre

Turf cut on new 7,200 square metre facility in Stevenage, UK
Design & Build

MSPS part of consortium to design new UK Cell Therapy Catapult Manufacturing Centre

Large-scale GMP manufacturing centre due to open in 2017 to support growth of UK cell therapy industry
Research & Development

UK cell therapy GMP manufacturing capacity is increasing, finds survey

Number of facilities and highly skilled jobs rises
Subscribe now